Nanovaccine for Eliciting Broadly Neutralizing Antibodies against HIV-1
Award Notice Posted
- Solicitation number
- 75N93024C00019
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Neovaxsyn Inc.
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- 75N93024C00019 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Ames, Iowa 50014, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services, has awarded a $2,000,000 contract to NEOVAXSYN INC for the development of a nanovaccine to elicit broadly neutralizing antibodies against HIV-1. The awarded contract number is 75N93024C00019 and was posted on July 1, 2024.
Notice text
Awarded contract 75N93024C00019 to NEOVAXSYN INC for 2000000.00 on 2024-07-01.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Nanovaccine for Eliciting Broadly Neutralizing Antibodies against HIV-1 | Award Notice | |
| This notice | Award Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity